0001181431-14-003675.txt : 20140123 0001181431-14-003675.hdr.sgml : 20140123 20140123192326 ACCESSION NUMBER: 0001181431-14-003675 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140121 FILED AS OF DATE: 20140123 DATE AS OF CHANGE: 20140123 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIVATION, INC. CENTRAL INDEX KEY: 0001011835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133863260 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 525 MARKET STREET STREET 2: 36TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 415-543-3470 MAIL ADDRESS: STREET 1: 525 MARKET STREET STREET 2: 36TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: ORION ACQUISITION CORP II DATE OF NAME CHANGE: 19960408 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rhodes Jennifer J CENTRAL INDEX KEY: 0001568249 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32836 FILM NUMBER: 14544197 MAIL ADDRESS: STREET 1: C/O MEDIVATION, INC. STREET 2: 525 MARKET ST., 36TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 4 1 rrd400395.xml 1/21/14 -- EXERCISE AND SALE X0306 4 2014-01-21 0 0001011835 MEDIVATION, INC. MDVN 0001568249 Rhodes Jennifer J C/O MEDIVATION, INC. 525 MARKET ST., 36TH FLOOR SAN FRANCISCO CA 94105 0 1 0 0 GC & Chief Compliance Officer Common Stock 2014-01-21 4 M 0 14000 47.48 D 20000 D Common Stock 2014-01-21 4 S 0 9400 76.05 D 10600 D Common Stock 2014-01-21 4 S 0 4300 76.66 D 6300 D Common Stock 2014-01-21 4 S 0 100 77.44 D 6200 D Common Stock 2014-01-21 4 S 0 100 78.14 D 6100 D Common Stock 2014-01-21 4 S 0 100 78.83 D 6000 D Stock Option (Right to Buy) 47.48 2014-01-21 4 M 0 14000 0.00 D 2022-07-16 Common Stock 14000 42000 D Shares were sold pursuant to a 10b5-1 plan. The shares were sold at prices ranging from $75.41 to $76.40. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $76.41 to $77.36. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares subject to the option vest according to the following schedule: 25% of the shares subject to the option (rounded down to the next whole number of shares) vested on July 16, 2013, and 1/48th of the shares subject to the option (rounded down to the next whole number of shares) shall vest on the first day of each full month thereafter. /s/ Jennifer Rhodes 2014-01-23